REGULAR SUPPORT MEETINGS

Arroyo Grande

MONTHLY - 2nd Tuesdays - 6pm - 8pm

via Zoom during the pandemic

contacts: Carl Deriso & Sarah Kirwin

Goleta

MONTHLY - 3rd Fridays - 12pm - 1:30pm

Goleta Valley Community Ctr, 5679 Hollister Ave, 93117

contact: Mike Jack

Thousand Oaks

MONTHLY - 2nd Thursdays - 1pm - 3pm

Goebel Adult Community Ctr, 1385 E Janss Rd

contact: Darlene Feigen - thousandoaksmssupportgroup.org

Ventura

MONTHLY - 3rd Fridays - 11:30am - 1pm

Denny's Restaurant, 4095 Telegraph Rd. (via teleconf during pandemic)

contacts: Donna Nowland (Co-Leader)

My Health StudioThe My Heath Studio Gym in Thousand Oaks is designed and built specifically for people with MS. Visit myhealthstudio.com

The following studies are underway in the late stages of research. We're watching them closely.

MS

October 20, 2020
Anti-inflammatory therapy shows promise in slowing progression of multiple sclerosis

https://www.sciencedaily.com/releases/2020/10/201020131338.htm 

December 20, 2020
Researchers have identified an immune cell in mice that promotes axon regeneration and neuronal survival and could potentially be harnessed as a treatment for brain, spinal cord, and optic nerve damage.

https://journals.lww.com/neurotodayonline/Fulltext/2020/12030/A_Newly_Identified_Immune_Cell_Promotes_Axon.2.aspx

Regrowing Myelin

Simple sugar possible therapy for repairing myelin in multiple sclerosis

https://www.sciencedaily.com/releases/2020/10/201007145416.htm

Mechanisms identified to restore myelin sheaths after injury or in multiple sclerosis 

https://www.sciencedaily.com/releases/2020/08/200824105529.htm

 

Pain

Advances with Long Non-Coding RNAs in Diabetic Peripheral Neuropathy (A peer-reviewed study)

https://www.dovepress.com/advances-with-long-non-coding-rnas-in-diabetic-peripheral-neuropathy-peer-reviewed-fulltext-article-DMSO

Kolon begins testing gene therapy for neuropathic pain in US

http://www.koreabiomed.com/news/articleView.html?idxno=8095

EicOsis EC5026 Granted Fast Track Designation by FDA for Neuropathic Pain

https://www.prnewswire.com/news-releases/eicosis-ec5026-granted-fast-track-designation-by-fda-for-neuropathic-pain-301037943.html

EC5026 just passed Phase 1a Clinical Trial, Nov 15, 2020:

https://www.prnewswire.com/news-releases/eicosis-successfully-completes-phase-1a-clinical-trial-of-ec5026-301174243.html